TENNESSEE PHARMACISTS RESEARCH AND… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1990

Legal Domicile

Principal Officer

DR ANTHONY PUDLO

Phone

6152563023

Tax Period

2023-01-01 to 2023-12-31

TENNESSEE PHARMACISTS RESEARCH AND EDUCATION FOUNDATION, founded in 1990, is a community nonprofit that reported $6.1M in total revenue in fiscal year 2023. Revenue surged 405% from the prior year, signaling strong growth momentum. Expenses of $5.8M left a modest 5% surplus.

Mission

THE TENNESSEE PHARMACISTS RESEARCH & EDUCATION FOUNDATION WAS ESTABLISHED FOR THE PURPOSE OF RECEIVING AND PROVIDING FUNDS FOR RESEARCH AND EDUCATION ON ISSUES RELATING TO CONSUMER AND PUBLIC HEALTH INTERESTS AND SERVICES PROVIDED BY THE PHARMACY PROFESSION AND THE HEALTHCARE DELIVERY SYSTEM.

Program Service Accomplishments

Program 1

Expenses: $4,926,955

THE CLOSING THE GAP COHORT HAS 95 PHARMACIES PARTICIPATING AND SUPPORTING LOCAL COMMUNITIES WITH NEARLY 56,000 INITIAL PATIENT VISITS AND OVER 35,000 VACCINATIONS ADMINISTERED.

Program 2

Expenses: $104,829

IN 2023, TPREF CONCLUDED A 5-YEAR GRANT WITH THE DEPARTMENT OF HEALTH AND THE CDC TO IMPROVE THE HEALTH OF AMERICANS THROUGH PREVENTION AND MANAGEMENT OF DIABETES, HEART DISEASE, AND STROKE. TPREF...

IN 2023, TPREF CONCLUDED A 5-YEAR GRANT WITH THE DEPARTMENT OF HEALTH AND THE CDC TO IMPROVE THE HEALTH OF AMERICANS THROUGH PREVENTION AND MANAGEMENT OF DIABETES, HEART DISEASE, AND STROKE. TPREF WORKED WITH 60 DIFFERENT PHARMACY SITES ON GAINING ACCREDITATION FROM THE AMERICAN ASSOCIATION OF DIABETES EDUCATORS (AADE) TO INCREASE AVAILABLE STRUCTURED EDUCATION OPPORTUNITIES FOR PATIENTS WITH DIABETES. TPREF ALSO GUIDED THE COLLABORATION BETWEEN PHARMACISTS AND PHYSICIANS TO INCREASE THE UTILIZATION OF COLLABORATIVE PRACTICE AGREEMENTS TO MANAGE PATIENTS MORE EFFECTIVELY, WHILE ALSO PROVIDING ADDITIONAL TOOLS AND RESOURCES.

Program 3

Expenses: $209,658

THE TPRN PROGRAM PROVIDES A PEER ASSISTANCE PROGRAM CONSISTING OF CONSULTATION, PREVENTION, REFERRAL, MONITORING AND ADVOCACY SERVICES FOR PHARMACY PROFESSIONALS WHO ARE IMPAIRED, SUFFER FROM...

THE TPRN PROGRAM PROVIDES A PEER ASSISTANCE PROGRAM CONSISTING OF CONSULTATION, PREVENTION, REFERRAL, MONITORING AND ADVOCACY SERVICES FOR PHARMACY PROFESSIONALS WHO ARE IMPAIRED, SUFFER FROM SUBSTANCE USE DISORDER INVOLVING ALCOHOL OR OTHER DRUGS, OR HAVE MENTAL HEALTH ISSUES. TPRN SERVED 88 INDIVIDUALS DURING THE 2023 CONTRACT YEAR.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $6,054,381

Program Service Revenue $0

Investment Income $396

Other Revenue $75,856

TOTAL REVENUE $6,130,633

Expense Breakdown

Grants Paid $2,632,714

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $5,451,716

Other Expenses $3,188,732

TOTAL EXPENSES $5,821,446

Year-over-Year Comparison

	2023	2022	Change
Revenue	$6,130,633	$1,215,177	+4.0%
Expenses	$5,821,446	$1,092,517	+4.3%
Net Income	$309,187	$122,660	+1.5%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$241,702

Total Directors

$170,368

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ANTHONY PUDLO	CHIEF EXECUTIVE OFFICER	30.00	Officer Director	$0	$15,246	$170,368
KIM JONES END 623	PRESIDENT	2.00	Officer Director	$0	$0	$0
JAY PHIPPS	PRES ELECT/PRESIDENT	2.00	Officer Director	$0	$0	$0
JEFF LEWIS	TRUSTEE/PRES ELECT	2.00	Officer Director	$0	$0	$0
JIMMY TORR END 623	TREASURER	2.00	Officer Director	$0	$0	$0
CHRIS FINCH START 623	TREASURER	2.00	Officer Director	$0	$0	$0
MARY JO COLLINS START 623	TRUSTEE	2.00	Director	$0	$0	$0
RICK SAIN END 623	TRUSTEE	2.00	Director	$0	$0	$0
JASON GREENE START 623	TRUSTEE	2.00	Director	$0	$0	$0
HILLARY BLACKBURN START 623	TRUSTEE	2.00	Director	$0	$0	$0
MARCUS DORTCH START 623	TRUSTEE	2.00	Director	$0	$0	$0
SHAWNA LIGHTFOOT END 1223	CONTROLLER	2.00	Officer	$0	$10,911	$71,334

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$6,130,633	$5,821,446	$2,302,989	$309,187
2022	$1,215,177	$1,092,517	$1,712,679	$122,660
2021	$372,333	$464,047	$1,109,479	$-91,714
2020	$813,290	$768,105	$1,600,591	$45,185
2019	$560,732	$668,477	$1,389,785	$-107,745
2018	$726,849	$549,503	$1,221,728	$177,346

TENNESSEE PHARMACISTS RESEARCH AND EDUCATION FOUNDATION